Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

Q: What does CUSIP 09203E105 represent in this 13F holders report?

CUSIP 09203E105 is the security identifier for BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q1 2022?

69 institutional investors reported BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: 09203E105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 58,000,000
Total 13F shares: 22,887,182
Share change: -293,537
Total reported value: $64,088,307
Price per share: $2.77
Number of holders: 69
Value change: -$2,429,770
Number of buys: 29
Number of sells: 44

Quarterly Holders Quick Answers

What is CUSIP 09203E105?
CUSIP 09203E105 identifies BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 09203E105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BDTX - Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Bellevue Group AG	13F	Company	6%	3,463,000	$18,458,000	—	31 Dec 2021	13F
NEA Management Company, LLC	13F	Company	5.9%	3,449,845	$18,388,000	—	31 Dec 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	4.5%	2,589,904	$13,804,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	3.9%	2,248,467	$11,985,000	—	31 Dec 2021	13F
Boxer Capital, LLC	13F	Company	3.5%	2,014,858	$10,739,000	—	31 Dec 2021	13F
Artal Group S.A.	13F	Company	2.8%	1,646,517	$8,776,000	—	31 Dec 2021	13F
FEDERATED HERMES, INC.	13F	Company	1.8%	1,035,135	$5,517,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	1.7%	1,014,791	$5,409,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	1.3%	773,928	$4,127,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.68%	396,167	$2,111,000	—	31 Dec 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.66%	385,400	$2,054,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	0.63%	364,653	$1,944,000	—	31 Dec 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.52%	301,002	$1,604,000	—	31 Dec 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.47%	272,035	$1,450,000	—	31 Dec 2021	13F
MPM BioImpact LLC	13F	Company	0.41%	239,888	$1,279,000	—	31 Dec 2021	13F
NORGES BANK	13F	Company	0.36%	210,300	$1,121,000	—	31 Dec 2021	13F
DAFNA Capital Management LLC	13F	Company	0.36%	206,100	$1,099,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.35%	201,455	$1,074,000	—	31 Dec 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.34%	198,500	$1,058,000	—	31 Dec 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.34%	197,595	$1,054,000	—	31 Dec 2021	13F
Ikarian Capital, LLC	13F	Company	0.26%	150,484	$801,000	—	31 Dec 2021	13F
Hawkeye Capital Management, LLC	13F	Company	0.26%	150,000	$800,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.23%	132,156	$704,000	—	31 Dec 2021	13F
Tekla Capital Management LLC	13F	Company	0.23%	131,990	$704,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.15%	89,551	$477,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	84,047	$419,000	—	31 Dec 2021	13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	13F	Company	0.13%	75,000	$400,000	—	31 Dec 2021	13F
PDT Partners, LLC	13F	Company	0.13%	74,036	$395,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	60,313	$322,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.1%	59,125	$316,000	—	31 Dec 2021	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.09%	54,257	$289,000	—	31 Dec 2021	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.08%	46,426	$247,000	—	31 Dec 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.08%	44,481	$237,000	—	31 Dec 2021	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.08%	44,000	$235,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.07%	42,597	$227,000	—	31 Dec 2021	13F
Jump Financial, LLC	13F	Company	0.07%	39,300	$209,000	—	31 Dec 2021	13F
CREDIT SUISSE AG/	13F	Company	0.07%	38,470	$205,000	—	31 Dec 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	38,437	$205,000	—	31 Dec 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.07%	37,805	$202,000	—	31 Dec 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.06%	37,502	$200,000	—	31 Dec 2021	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.06%	36,920	$197,000	—	31 Dec 2021	13F
NOMURA HOLDINGS INC	13F	Company	0.06%	35,061	$189,000	—	31 Dec 2021	13F
Trexquant Investment LP	13F	Company	0.06%	34,809	$186,000	—	31 Dec 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	34,500	$184,000	—	31 Dec 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.06%	32,205	$172,000	—	31 Dec 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	30,813	$164,000	—	31 Dec 2021	13F
UBS Group AG	13F	Company	0.05%	29,554	$157,000	—	31 Dec 2021	13F
Walleye Capital LLC	13F	Company	0.05%	27,131	$145,000	—	31 Dec 2021	13F
HSBC HOLDINGS PLC	13F	Company	0.04%	26,036	$143,000	—	31 Dec 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.04%	24,754	$132,000	—	31 Dec 2021	13F

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) as of Q1 2022

As of 31 Mar 2022, Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,887,182 shares. The largest 10 holders included NEA Management Company, LLC, Bellevue Group AG, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., BOXER CAPITAL, LLC, Artal Group S.A., FEDERATED HERMES, INC., VANGUARD GROUP INC, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

Q1 2022 holders

Holder diff

-14

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.